Evidence map›Paper›PMID 37005963›Full record

ArticleEuropean journal of applied physiology2023

Regional and time course differences in sweat cortisol, glucose, and select cytokine concentrations during exercise.

Michelle A King, Shyretha D Brown, Kelly A Barnes, Peter John D De Chavez, Lindsay B Baker

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in European journal of applied physiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04240951 (Validity of a Prototype Wearable Patch in Measuring Local Sweating Rate and Sweat Electrolyte Concentration During Exercise), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04240951 nacompletednot on this map

Validity of a Prototype Wearable Patch in Measuring Local Sweating Rate and Sweat Electrolyte Concentration During Exercise

TypeinterventionalSponsorPepsiCo Global R&DRan2017 to 2020Enrolled552ConditionsSweat AnalysisArmsSweat patch
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Development of a noninvasive device and method for measuring immune parameters in skin disease.JID innovations : skin science from molecules to population health · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Michelle A KingGatorade Sports Science Institute, PepsiCo R&D Life Sciences, Barrington, IL, USA.
Shyretha D BrownGatorade Sports Science Institute, PepsiCo R&D Life Sciences, Barrington, IL, USA.
Kelly A BarnesGatorade Sports Science Institute, PepsiCo R&D Life Sciences, Barrington, IL, USA.
Peter John D De ChavezData Science and Analytics, PepsiCo R&D, Barrington, IL, USA.
Lindsay B BakerGatorade Sports Science Institute, PepsiCo R&D Life Sciences, Barrington, IL, USA. lindsay.baker@pepsico.com.ORCID http://orcid.org/0000-0002-6588-9424
Gatorade Sports Science Institute · USPepsiCo (United Kingdom) · GBPepsi (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe use of sweat as a biofluid for non-invasive sampling and diagnostics is a popular area of research. However, concentrations of cortisol, glucose, and cytokines have not been described across anatomical regions or as time progresses throughout exercise. PURPOSE: To determine regional and time course differences in sweat cortisol, glucose, and select cytokines (EGF, IFN-γ, IL-1β, IL-1α, IL-1ra, TNF-α, IL-6, IL-8, and IL-10).

methodsSweat was collected with absorbent patches from eight subjects (24-44 y; 80.2 ± 10.2 kg) on the forehead (FH), right dorsal forearm (RDF), right scapula (RS), and right triceps (RT) at 0-25 min, 30-55 min, and 60-85 min during 90 min of cycling (~ 82% HR

resultsThere was a significant effect of location on sweat analyte concentrations with FH having higher values than most other regions for cortisol (FH: 1.15 ± 0.08 ng/mL > RDF: 0.62 ± 0.09 ng/mL and RT: 0.65 ± 0.12 ng/mL, P = 0.02), IL-1ra (P < 0.0001), and IL-8 (P < 0.0001), but lower concentrations for glucose (P = 0.01), IL-1α (P < 0.0001), and IL-10 (P = 0.02). Sweat IL-1β concentration was higher on the RS than RT (P < 0.0001). Sweat cortisol concentration increased (25 min: 0.34 ± 0.10 ng/mL < 55 min: 0.89 ± 0.07 ng/mL < 85 min: 1.27 ± 0.07 ng/mL; P < 0.0001), while EGF (P < 0.0001), IL-1ra (P < 0.0001), and IL-6 (P = 0.02) concentrations decreased over time.

conclusionSweat analyte concentrations varied with time of sampling and anatomical region, which is essential information to consider when conducting future work in this area. CLINICAL TRIAL IDENTIFIER: NCT04240951 registered January 27, 2020.

Indexed as

CytokinesSweatEpidermal Growth FactorGlucoseHumansHydrocortisoneInterleukin-10Interleukin 1 Receptor Antagonist ProteinInterleukin-6Interleukin-8CytokinesEpidermal Growth FactorGlucoseHydrocortisoneInterleukin-10Interleukin 1 Receptor Antagonist ProteinInterleukin-6Interleukin-8BiomarkersChemokinesExcretion rateThermoregulation

Identifiers

PMID37005963
PMCPMC10363073
OpenAlexW4362506184

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.